GINKGO BIOWORKS HOLDINGS, INC. Cash and Cash Equivalents
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Cash and Cash Equivalents of $84.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $84.53M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $143.86M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $167.20M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $111.06M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $84.53M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $143.86M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $167.20M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $111.06M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $203.57M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $312.42M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $561.57M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $616.21M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $730.37M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $840.44M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $944.07M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.05B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.11B 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $1.21B 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $1.32B 10-K · filed 2026-02-26 | |
| 2022-09-30 | $1.30B 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.38B 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $1.49B 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $1.55B 10-K · filed 2025-02-25 | |
| 2021-09-30 | $1.74B 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $235.89M 10-Q · filed 2022-08-15 | $37.63K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $308.13M 10-Q · filed 2022-05-16 | $1.92M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $380.80M 10-K · filed 2024-02-29 | $0.00 10-Q · filed 2021-05-24 |
| 2020-09-30 | $471.06M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $495.29M 10-K · filed 2023-03-13 |